SEATTLE--(BUSINESS WIRE)--Kineta announced today it has been awarded its second NIH contract in twelve months – the latest focused on mining vast, existing, basic research databases with the goal of identifying new drug targets and candidates. The project will be directed at five key therapeutic areas: infectious, cardiovascular, neurological, metabolic and autoimmune diseases.
